RxDoctor Payments Data

Tanya Uthup

Nurse Practitioner · Skokie, ILNPI 1124443031

Payments from drug & device makers

$2,223in general payments, 2019–2025

Across 41 payments — averaging $54.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$786
  • Axsome Therapeutics, Inc.$241
  • Teva Pharmaceuticals USA, Inc.$231
  • Lundbeck LLC$225
  • Pfizer$147
  • SK Life Science, Inc.$125
  • plus $468 from 12 others

What the payments were for

  • Food & beverage$2,223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,223 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$40,464
Medicare patients
138
Services billed
1,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate73$115,621
Aimovig AutoinjectorErenumab-Aooe67$55,135
UbrelvyUbrogepant46$51,709
Emgality PenGalcanezumab-Gnlm52$48,350
Ajovy AutoinjectorFremanezumab-Vfrm29$34,019
QuliptaAtogepant22$26,931
Topiramate44$575
Sumatriptan Succinate20$394
Amitriptyline Hcl15$382
Venlafaxine Hcl ErVenlafaxine Hcl14$253
RizatriptanRizatriptan Benzoate17$232
Gabapentin16$219
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine15$161
Nortriptyline Hcl16$154
Dexamethasone14$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$147$115,62173 claims
AbbVieUbrelvy, Qulipta$786$78,64068 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →